Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2024 | What role does FDG-PET have in managing bladder cancer?

Antonio Cigliola, MD, IRCCS San Raffaele Hospital, Milan, Italy, comments on the role of fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of urothelial carcinoma. In addition to assessing lymph node involvement, FDG-PET can evaluate responses after neoadjuvant treatment in a functional manner. This interview took place at the ASCO GU Cancers Symposium 2024 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.